scholarly journals A case of non-small cell lung cancer presenting anti-amphiphysin antibody-positive paraneoplastic neurological syndrome

2021 ◽  
pp. 101525
Author(s):  
Koki Nakashima ◽  
Yuya Fujii ◽  
Masayuki Sato ◽  
Kazunari Igarashi ◽  
Motohiro Kobayashi ◽  
...  
Haigan ◽  
2016 ◽  
Vol 56 (3) ◽  
pp. 199-204
Author(s):  
Taito Yamago ◽  
Masaki Hanibuchi ◽  
Hirokazu Ogino ◽  
Nagahisa Murakami ◽  
Ryuji Kaji ◽  
...  

2012 ◽  
Vol 1 (3) ◽  
pp. 151-154
Author(s):  
Hirohide Kutsuma ◽  
Kazunari Yamana ◽  
Yoshiaki Nagai ◽  
Shintaro Mikami ◽  
Hiroyuki Kyoyama ◽  
...  

2019 ◽  
Author(s):  
Wenqi Zheng ◽  
Xiaolei Wang ◽  
Lihua Sun ◽  
Hui Deng ◽  
Yanqiu Han ◽  
...  

Abstract Background Paraneoplastic neurological syndromes (PNS) are rare disorders affecting any part of the central, peripheral or autonomic nervous system that occur in association with cancer. Among cancer patients, less than 1% overall develop PNS. Anti- SOX1 antibodies positive paraneoplastic neurological disorders are rare and most often associated with small cell lung cancer (SCLC). Case presentation Herein, we report a case of a 61-year-old male presented with an unusual anti- SOX1 positive PNS. Electrodiagnostic study showed notable low amplitude motor potentials and high amplitude motor potentials of the right tibialis anterior suggesting the presence of Lambert–Eaton myasthenic syndrome (LEMS). Typical MRI and PET-CT found a hyperintense lesion with contrast enhancement in the thorax in front of 5-6 centrum of vertebrae, and thoracoscopic biopsy revealed pathological findings for SCLC. Because the diagnosis was made in time, the patient is currently receiving chemotherapy and radiotherapy for the cancer at Chinese PLA General Hospital, and the clinical symptoms improved obviously. Conclusions The comprehensive screening of onconeural antibodies in PNS-suspicious cases combined with early diagnosis and treatment of tumor are important for achieving a good outcome.


2022 ◽  
Vol 2022 ◽  
pp. 1-5
Author(s):  
Koki Nakashima ◽  
Yoshiki Demura ◽  
Kosuke Kurokawa ◽  
Toshihiro Takeda ◽  
Norihiro Jikuya ◽  
...  

Paraneoplastic neurological syndrome (PNS) is associated with malignancies, including small-cell lung cancer. Recently, PNS cases among patients with small-cell lung cancer (SCLC) induced by immune checkpoint inhibitors have increased. We herein report a 66-year-old man with SCLC who developed disorientation, dysphagia, and gait disturbance after three courses of treatment with atezolizumab. Brain magnetic resonance imaging revealed a high-intensity area in the bilateral temporal lobes. Blood test results were positive for anti-Hu and anti-Zic4 antibodies, which led to the diagnosis of limbic encephalitis as PNS. Some symptoms improved with intravenous administration of steroids and immunoglobulins.


Sign in / Sign up

Export Citation Format

Share Document